Posted by:
[ad_1]
18-MC is a proprietary, non-hallucinogenic molecule, based on the psychedelic ibogaine. In extensive nonclinical testing, 18-MC has shown promise …
[ad_2]
Source link
Tom Brown discuss the potential benefits of ibogaine, an African shrub that is being used to treat opioid addiction. Recently, Tom worked on a study to find how effective ibogaine treatment was for opioid addiction. This study showed that ibogaine is effective for detoxing, reducing opioid use, and providing long-term improvement in social and family status. The steady and rapid growth of ibogaine treatment could change the future ...
Ibogaine Treatment and the Opioid Crisis: Past, Present, and Future
Thomas Kingsley Brown, Ph.D.
The Sleeping Octopus Assembly on Psychedelics (SOAP) is an intimate conference that explored the role of psychedelics in science, medicine, policy, and culture, which took place at a historic mansion in Pittsburgh, Pennsylvania, from July 13-15, 2018.
This conference featured presentations from key figures in the psychedelic research and policy community, a psychedelic-themed comedy show, ...
Continue Reading → [ad_1]
Ibogaine produces powerful hallucinations for four to six hours. As a psychedelic, its most distinguishing characteristic is its oneirogenic quality, …
[ad_2]
Source link
Posted by:
Dosed is a feature documentary that has the power to help the 300 million people in the world suffering from illnesses like anxiety and depression, as well as the 1.3 billion people struggling with addictions of all kinds. Please get involved on social media @DoseMovie on instagram, facebook, twitter. Let’s get educated on this important cause and please donate to the film so we can make sure ...
Continue Reading →